Ty

pe1Di
abet
esMel
li
tusQui
z pati
ent’
streatment?
a.Self
-Mixed/Spl
it
1.Thefoll
owingar ethedif
fer
entsi
gnsand b.Basal-
Bolus
symptomsexper iencedbythepati
ent
,EXCEPT c.Pre-
mixed
a.Poly
dipsi
aandpol yur
iawit
hdehydr
ati
on d.Noneoft hese
b.Rapidweightloss
c.Lossofconsciousness 8.Whatpr obablestimulusi
nit
iat
edt
heonsetoft
he
d.Hypoventi
lat
ion diseaseint hepat i
ent?
a.Rubellai nf
ect i
on
2.Type1Di abetesMel li
tus(T1DM)i tsel
fi snot b.CMVi nfection
i
nherit
ed,butapr edispositi
ont odevelopingthe c.IngestionofCowMi lk
condit
ioncanr uninf amili
es.Ther i
skofdev elopi
ng d.COVI D-19i nfecti
on
T1DM isincreasedbyhav i
ngcer tai
nv ar
iantsof
genes,suchasHLADR3andHLADR4. 9.Dif
ferentvi
rusescanbeassociat
edwiththe
a.Bothstatementsar ecor r
ect i
nvolvementoft ype1DM andtheseincl
udethe
b.Bothstatementsar eincorrect fol
lowing,EXCEPT
c.Onlythefir
ststatementi scor r
ect a.Mumps
d.Onlythesecondst atementi scorrect b.CMV
c.COVI D-
19
3.Thefollowingar eaut
oimmunedi
seasest
hat d.Allofthese
i
ncreasest heriskofhavi
ngT1DM,EXCEPT:
a.Perni
ciousAnemi a 10.These2conditionsar ecommoncompl icat
ions
b.Celi
acDi sease ofdiabetes:
c.Rheumat oidAr t
hri
ti
s a.Hypogl y
cemiaandDi abeticKet
oacidosis
d.Type2Di abetesMell
it
us b.Hy pergl
ycemi
aandDi abeti
cKetoacidosi
s
c.DawnandSomogy i
Phenomena
4.Whichoft hefoll
owingis/ar
econsi
der
edaspar
t d.Hy pogly
cemiaandHy pergl
ycemia
ofthediagnosticcri
ter
iai
nTy pe1DM?
a.FPGof≥  200mg/ dL 11.Whatphasewher
ethenew-
onsetdi
abet
es
b.HbA1c ≥ 
6.5% hassomer esi
dualbeta-
cellf
unct
ionwhi
ch
c.Absenceofaut oanti
bodies reducestheneedf orexogenousi
nsul
in?
d.HighC-peptide a.Honey moonphase
b.Int
ensifi
cati
onphase
5.Basedont hegivencase, thepat
ientwasont he c.Duringrecover
y
3rdstageofT1DM dev el
opment .Whichofthe d.DuringDKA
foll
owingshowsani ndicati
onofsuchst age?
a.Asy mptomat i
c
12.Amer i
canDi abet
esAssociat
ion
b.Presenceofgr eaterthanorequal to2pancreat
ic
recommendst est
ingbl
oodsugarlevel
s:
autoanti
bodies
1.Beforemeal sandsnacks
c.Hy per
glycemiawi thcli
nicalsymptoms
2.Beforebed
d.2choi cesarecor r
ect
3.Beforeexercisi
ngordri
vi
ng
6.Whatwas/ar
ethecondi
ti
on/
soft
hepat
ient
? 4.Ifsuspect
edl owbloodsugar.
a.T1DM a.1,2
b.DKA b.2,3
c.MODY c.1,3,4
d.2choi
cesarecor
rect d.1,2,3,4

7.Whatwast
hesuggest
edi
nsul
i
nregi
menf
ort
he 13.Appr
ovedt
hef
ir
star
ti
fi
cial
pancr
easf
or
peopl
ewi
tht
ype1di
abet
eswhoar
eage14 b.FoodandDrugAdminist
rat
ion
andol
der
. c.Depart
mentofHealt
h
a.AmericanDiabetesAssoci
ati
on d.WorldHeal
thOrgani
zati
on
b.FoodandDr ugAdmi ni
str
ati
on
c.DepartmentofHealth 19.Whichamongt hef
oll
owi
ngi
snotasi
gnand
d.WorldHealthOrgani
zati
on symptom ofT1DM?
a.pol
ydipsia
14.Adv antageofAf r
ezzaasani nhaledinsuli
n. b.pol
yphagia
a.Maydev elopani ncreaseinser um antibody c.pol
yuria
l
ev el
sthoughnotr elatedtoanysi gnifi
cantcli
nical d.Noneoft hese
change
b.Smoki ngappear stoenhancei nsulinabsorption 20.Ty pe1DM i
smor
ecommoni
nfemal
est
hani
n
c.Itisadr ug-devi
cecombi nati
onpr oductwhi chis males.
rapidactinginhaledi nsuli
n,administeredatthe a.True
beginni
ngofeachmeal b.False
d.Signi
f i
cantdecr easei nDiff
usingCapaci tyof
Lungsf orCar bonMonoxi de(DLCO)r elati
veto
subcutaneousi nsulin.

15.Nephr opathyispresenti
n30%t o40%of
patient swithtype1diabetesandrepresentsthe
secondl eadingcauseofdeathforindi
vidualswit
h
diabet es.
a.Tr ue
b.Fal se

16.Whi chamongtheseI
CAar
eassoci
atedwi
th
T1DM?
I.IA-2
II.GAD-65
III.I
AA
IV.ZnT8
a.I I
b.I ,
III
c.I ,
II
,II
I,
IV
d.Noneoft hese

17.Whichamongt
heseagegr
oupsi
smost
ly
aff
ect
edbyLADA?
a.15-
20
b.20-
25
c.25-
30
d.30-
35

18.Theyr ecommendt esti

ngpatient
swi t
hdiabet
es
totestbloodsugarlevel
sbef or
emeal sandsnacks,
beforeexercisi
ngordriv
ing,andifonsuspici
onsof
havinglowbl oodsugar.
a.Amer i
canDi abet
esAssociati
on